Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-05-08
1993-01-05
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514188, 514814, 546 6, 549210, C07F 1502, A61K 31555, C07D21369, C07D30940
Patent
active
051770687
ABSTRACT:
Iron complexes comprising a ferric cation in combination with at least two different ligands, at least one of which is provided by a compound being:
REFERENCES:
patent: 2429096 (1947-10-01), Ladd et al.
patent: 2686786 (1953-08-01), Shaw et al.
patent: 2742476 (1953-10-01), Bernstein et al.
patent: 3281366 (1966-10-01), Judge et al.
patent: 3810752 (1974-05-01), Wilcox et al.
patent: 3864334 (1975-02-01), Pallos
patent: 3928616 (1975-12-01), Pallos
patent: 3968118 (1975-08-01), Lohaus et al.
patent: 4018907 (1977-04-01), Scarpellino
patent: 4018934 (1977-04-01), Parliment
patent: 4063927 (1977-12-01), Otten et al.
patent: 4181654 (1980-01-01), Weitl et al.
patent: 4225614 (1980-09-01), Hansson
patent: 4279936 (1981-07-01), Jones et al.
patent: 4293542 (1981-10-01), Lang et al.
patent: 4309305 (1982-01-01), Weitl et al.
patent: 4315942 (1982-02-01), Corden
patent: 4358455 (1982-11-01), Atkinson et al.
patent: 4396766 (1983-08-01), Farmer, Jr. et al.
patent: 4397867 (1983-08-01), Blake
patent: 4419365 (1983-12-01), McLachlan
patent: 4442305 (1984-04-01), Weitl et al.
patent: 4530963 (1985-07-01), DeVoe et al.
patent: 4543213 (1985-09-01), Weitl et al.
patent: 4550101 (1985-10-01), Hider
patent: 4575502 (1986-03-01), Hider
patent: 4585780 (1986-04-01), Hider et al.
patent: 4587240 (1986-05-01), Hider
patent: 4650793 (1987-03-01), Hider
patent: 4698431 (1987-10-01), Raymond et al.
Chemical Abstracts: 97:92048a (1982) Bartulin et al.
Merck Index (1976) 9th Edition, Merck & Co., Inc., Rahway, N.J. 543-544.
Chemical Abstracts: 94:156749c (1981) Shin-Etsu Chemical Industry Co. Ltd.
Chemical Abstracts: 98:71930n (1983) Harada, Rokuro.
Manufacturing Chemist & Aerosol News (May 1970) E. Jones.
Pharmaceutical Dosage Forms, vol. 3 (1982) Marcel Decker, pp. 165-167 Lieberman & Lachman.
Chemical Abstracts: 75:115362k (1971) Kidani et al.
Chemical Abstracts: 94:41144j (1981) Kimura et al.
Chemical Abstracts: 94:24201h (1981) Gerard et al.
Yaku Gaku Zasshi, 90 (10), 1222-1225, Yasue et al., "Synthesis from Maltol . . . ", (1970) and translation.
Chemical Abstracts, 1976, 85, 56109q, Katyal et al., "2,3-Dihydroxypyridine . . . ".
Talanta, 1974, 21, 763-769, Kushwaha et al., "Complexation reactions of pyridinols".
Chemical Abstracts, 1985, 102, 124493g, Scarrow et al., "Ferric ion sequestering agents . . . ".
"Symposium on Development of Iron Chelators for Clinical Use", Anderson & Hiller (Eds.), 1975, pp. 137-173, (Sept. 22, 1975).
Chem. Pharm. Bull., 1980, 28, 2570-2579, Kumira et al., "Central Depressant Effects of Maltol Analogs in Mice".
J. Chem. Res. (M), 1980, 3919-3927 paper F/016/80, Gerard et al., "Complexes ferriques du maltol . . . ".
Pfizer Technical Bull., 1974, Data Sheet No. 04/A, "Veltol".
Pfizer Technical Bull., 1974, No. 865 & 867, "Veltol and Veltol Plus".
Coll. Czech. Chem. Commun., 1968, 33, 4198-4214, Stefanovic et al., "On the reaction of iron(III) with maltol".
J. Coord. Chem., 1978, 8, 27-33, Habeeb et al., "Direct electrochemical synthesis of some metal chelate complexes".
J. Chem. Res. (S), 1980, 314, Gerard et al., "Iron complexes of maltol . . . ".
Nagoya Shiritsu Daigaku Yakugakubu Kenkyu Nempo, 1970, 18, 16-21 Kidani et al., "Synthesis of maltol-Fe(III) complex" (and translation).
Report of Iron Uptake from FeIII maltol, Jan. 1986, Maxton, Thompson & Hilder, "Human Studies".
Letter from University of Kansas Medical Center, Feb. 14, 1986, Skikne.
"Study to compare the effect of iron maltol versus ferrous sulphate in the correction of chronic iron deficiency anaemia", 1986, Blake.
Struct. Bonding (Berlin), 1984, 58, 25-87, Hider, "Siderophore Mediated Absorption of Iron".
Chemical Abstracts, 1981, 94, 24201h, Gerard et al., "Iron(III) complexes of maltol . . . ".
Journal of Pharmacy and Pharmacology, 1954, 6, 1037-1047, Johnson & Thomas, "The Stability of Aqueous Solutions of Ferrous Gluconate".
Buckingham et al., J. Chem. Soc., Chem. Comm. 1982, pp. 779-781.
Anderson et al., Journal of Inorganic Biochemistry, 1982, vol. 16, pp. 21-32.
Anderson, Ed, Symposium Proceedings, Bethesda, Md. (1975) pp. 137-173.
Ward, Aust. J. Biol. Sci., 1976, 29, pp. 189-196.
Tamhina, Croatica Chemica Acta CCACAA, 1973, 45, pp. 603-610.
Mentas, Ann. Chim., (Rome), vol. 66, Nos. 7-8, 1976, pp. 401-415.
Howlin, CA 97:173875v, (1982).
Mentasi, CA 87:157681s, (1976).
Bidiel, J. Chem. Soc., 69:1801 (1947).
Wilhaut, Helvetica Chimica Acta, vol. XXIX, fasciculus XII (1946), pp. 1669-1675.
Mohrle, Tetrahedron (1970), vol. 26, pp. 3779-3785.
Akera, J. Bacteriology, (Jan. 1980) vol. 141, No. 1, pp. 164-168.
Stunzi, Aust. J. Chem. (1979), 32, pp. 21-30.
Itoh et al., "The Journal of Antibiotics", vol. XXXII, No. 11, pp. 1089-1095 (Nov. 1979).
Barker et al., Journal of Antibiotics, vol. 32, No. 11, 1979, pp. 1096-1103.
McInnes et al., Journal of the Chemical Society, Chemical Communications, 1974, No. 8, 281-282.
Neilands, Science, 1967, 156, 1443-1447.
Dittmar et al., J. Med. Chem., 1974, 17, 753-756.
Durbin, P. W. et al., "Kinetics of Plutonium Deposition in the Mouse," Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Lab. (Apr. 1985).
Durbin, P. W. et al., "New Sequestering Agents for the Actinides . . . ," Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Lab. (Apr. 1985).
Raymond, K. N., "Specific Sequestering Agents for Iron and Actinides," in Environmental Inorganic Chemistry (VCH Publishers, Inc. 1985).
Riley, P. E. et al., Inorganic, 22, 3940 (1983).
Scarrow, R. C. et al., "Ferric Ion Sequestering Agents . . . ," Inorganic Chemistry 24 (1985), pp. 954 et seq.
CA 93:130476r.
EP-A-0 094 149.
DE-A-25554111 (May 1925).
Painippon, CA 64:3504d.
Yasur, Yakugaku Zasshi (1970) 90, p. 1222.
J. Am. Chem. Soc. (1956) 78, p. 622.
Hashiguchi, Mol. Pharm. (1977) 13, pp. 362-367.
Hare, J. Med. Chem. (1974) vol. 17, No. 1, pp. 1-5.
CA 97:92048a.
Gerard, J. Chem. Research, (S) (1978), pp. 404-405.
Needijk, Recueil (1972) 91, pp. 681-687.
Bull. Chem. Soc. Japan (1976), vol. 49, pp. 2461-2464.
Evans, "Biological Aspects of Metals and Metal Related Diseases", New York (1983), pp. 81-88.
Bull. Soc. Chim. (1979), No. 11-12, pp. I-451 to I-456.
Weatherall et al. (eds.), Oxford Textbook Medicine, Ox. Univ. Press, vol. 1 (1983), p. 7.
Martindale, The Extra Pharmacopoeia, The Pharm. Press (1973), pp. 81 and 739.
Barker, CA 92, 179021g (1980).
Mueller, CA 103, 192908 (1985).
Callingham Brian A.
Hider Robert C.
Kontoghiorghes George
Stockham Michael A.
Berch Mark L.
National Research Development Corporation
LandOfFree
Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2390662